Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: CERUS CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-06-12 to 2024-06-18
Current total value of award: $87166.08
Description: THE INTERCEPT BLOOD SYSTEM FOR PLATELETS IS USED TO INACTIVATE A BROAD SPECTRUM OF VIRUSES, BACTERIA, PROTOZOA AND CONTAMINATING DONOR LEUKOCYTES IN PLATELET COMPONENTS.